What is Malignant Ameloblastoma?
Malignant ameloblastoma is a rare, slow-growing tumour that originates in the jawbone, often near the molars in the lower jaw. It arises from ameloblasts, the cells responsible for forming tooth enamel. While most ameloblastomas are benign, they can sometimes become aggressive or malignant, causing significant structural damage to the jaw and surrounding tissues.
This condition primarily affects African and Asian individuals between the ages of 30 and 60. Among all diagnosed cases, malignant ameloblastoma accounts for approximately 2%.
Causes of Malignant Ameloblastoma
Ameloblastomas develop due to the abnormal and rapid growth of ameloblast cells after tooth enamel formation is complete. Although the exact cause is unclear, certain genetic mutations, particularly in the BRAF and SMO genes, are often linked to these tumours. These mutations disrupt normal cell division, promoting tumour growth.
Signs and Symptoms
Ameloblastoma grows slowly and may remain asymptomatic for 10–20 years. Common symptoms include:
- Painless swelling on one side of the jaw
- Presence of a mass or growth in the neck
- Red or pink spots on teeth that may chip or break easily
- Loose teeth
- Difficulty moving the jaw
- Red, swollen, or inflamed gums
Diagnosis
The following methods are used to diagnose malignant ameloblastoma:
- Imaging Tests: X-rays, MRI, CT scans, and PET scans are used to assess the tumour’s size, location, and potential malignancy.
- Tumour Biopsy: A sample of the tumour is examined under a microscope to confirm the diagnosis and identify the type of ameloblastoma.
Treatment Options
Treatment depends on the size, type, and progression of the tumour. Common approaches include:
- Surgery: Complete removal of the tumour along with a significant portion of the surrounding bone and tissue to prevent recurrence and spread.
- Conservative Surgery: For small, less invasive tumours, a smaller portion of bone and tissue is removed while still ensuring effective treatment.
- Radiation Therapy: Often used alongside surgery or chemotherapy to eliminate any remaining tumour cells.
- Reconstructive Surgery: Bone grafts are used to rebuild the jaw after tumour removal.
- Nutritional Guidance: Dietary modifications are recommended during the healing process to support recovery.
Prognosis (Outcome)
- Recurrence: Up to 20% of ameloblastomas recur, typically within five years after treatment.
- Monitoring: Lifetime follow-up care is essential to detect and manage potential recurrences early.
With proper treatment and ongoing care, patients can significantly improve their quality of life and reduce the risk of complications.
You can help us with your donation:
Without a Ribbon is a charity that works hard to aid those who suffer from rare cancers. You can help our cause in a variety of ways: